Vistance Networks (VISN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Feb, 2026Executive summary
Completed sale of CCS segment to Amphenol in January 2026, using $10 billion in proceeds to repay all debt and redeem preferred equity.
Renamed to Vistance Networks, now focused on Aurora and Ruckus segments, with financials recast to reflect continuing operations.
Delivered strong 2025 growth: net sales up 40% to $1.93B, core adjusted EBITDA up 176% to $379M, and significant margin expansion.
Ended 2025 with $923M in cash and $1.54B in liquidity, up 31% from prior quarter.
Positioned for continued growth in 2026, leveraging DOCSIS 4.0 and Wi-Fi 7 upgrade cycles.
Financial highlights
Core net sales for Q4 2025: $515M, up 24% year-over-year; full year: $1.93B, up 40%.
Core adjusted EBITDA for Q4 2025: $99M, up 55% year-over-year; full year: $379M, up 176%.
Adjusted EPS for 2025: $0.77 vs $0.10 in 2024; Q4 adjusted EPS: $0.17 vs $0.14 in Q4 2024.
Free cash flow for 2025: $252.6M; Q4 free cash flow: $64.5M.
Gross profit margin for 2025: 49.5%, up from 43.8% in 2024.
Outlook and guidance
2026 core adjusted EBITDA guidance: $350M–$400M.
Special distribution of at least $10/share planned by end of April 2026.
Ruckus expected to deliver low teen adjusted EBITDA growth; Aurora EBITDA to decline as legacy business normalizes.
Aurora revenue expected to grow in 2026, but EBITDA to decline due to mix and stranded costs.
Ruckus revenue expected to grow in the mid-teens, outpacing the market.
Latest events from Vistance Networks
- Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Proxy outlines director elections, executive pay, auditor ratification, and major ESG progress.VISN
Proxy filing23 Mar 2026 - Adjusted EBITDA up nearly 20% as CCS growth offsets declines; $2.1B OWN/DAS sale to aid liquidity.VISN
Q2 20242 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Core adjusted EBITDA up 159% on 23.5% sales growth; 2025 guidance reaffirmed.VISN
Q1 202524 Dec 2025 - Q4 core sales jumped 27% and margins rose, with 2025 EBITDA guidance at $1.00–$1.05B.VISN
Q4 202421 Dec 2025 - Definitive agreement to sell CCS segment to Amphenol, pending shareholder approval and regulatory review.VISN
Proxy Filing2 Dec 2025 - CCS business sale unlocks equity, enables debt repayment, and sets up a major shareholder dividend.VISN
Proxy Filing1 Dec 2025 - $10.5B sale of CCS segment to Amphenol, pending approvals and board support.VISN
Proxy Filing1 Dec 2025